These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30429055)

  • 1. TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling.
    Sin STK; Li Y; Liu M; Ma S; Guan XY
    Gynecol Oncol; 2019 Jan; 152(1):185-193. PubMed ID: 30429055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.
    Shen MR; Hsu YM; Hsu KF; Chen YF; Tang MJ; Chou CY
    Carcinogenesis; 2006 May; 27(5):962-71. PubMed ID: 16400188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.
    Lovly CM; McDonald NT; Chen H; Ortiz-Cuaran S; Heukamp LC; Yan Y; Florin A; Ozretić L; Lim D; Wang L; Chen Z; Chen X; Lu P; Paik PK; Shen R; Jin H; Buettner R; Ansén S; Perner S; Brockmann M; Bos M; Wolf J; Gardizi M; Wright GM; Solomon B; Russell PA; Rogers TM; Suehara Y; Red-Brewer M; Tieu R; de Stanchina E; Wang Q; Zhao Z; Johnson DH; Horn L; Wong KK; Thomas RK; Ladanyi M; Pao W
    Nat Med; 2014 Sep; 20(9):1027-34. PubMed ID: 25173427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-375 Affects the Proliferation, Invasion, and Apoptosis of HPV16-Positive Human Cervical Cancer Cells by Targeting IGF-1R.
    Yu X; Zhao W; Yang X; Wang Z; Hao M
    Int J Gynecol Cancer; 2016 Jun; 26(5):851-8. PubMed ID: 27206217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expression.
    Bie CQ; Liu XY; Cao MR; Huang QY; Tang HJ; Wang M; Cao GL; Yi TZ; Wu SL; Xu WJ; Tang SH
    Oncotarget; 2016 Nov; 7(48):79305-79318. PubMed ID: 27813495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor 1 receptor mediated tyrosine 845 phosphorylation of epidermal growth factor receptor in the presence of monoclonal antibody cetuximab.
    Iyer G; Price J; Bourgeois S; Armstrong E; Huang S; Harari PM
    BMC Cancer; 2016 Oct; 16(1):773. PubMed ID: 27716204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphoma.
    Vishwamitra D; Curry CV; Alkan S; Song YH; Gallick GE; Kaseb AO; Shi P; Amin HM
    Mol Cancer; 2015 Feb; 14():53. PubMed ID: 25884514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma.
    Zhou X; Fang X; Jiang Y; Geng L; Li X; Li Y; Lu K; Li P; Lv X; Wang X
    J Hematol Oncol; 2017 Feb; 10(1):37. PubMed ID: 28153033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin restores crizotinib sensitivity in crizotinib-resistant human lung cancer cells through inhibition of IGF1-R signaling pathway.
    Li L; Wang Y; Peng T; Zhang K; Lin C; Han R; Lu C; He Y
    Oncotarget; 2016 Jun; 7(23):34442-52. PubMed ID: 27144340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of insulin-like growth factor 1 receptor and its inhibitor AG1024 on the progress of lung cancer.
    Wei YH; Tang HX; Liao YD; Fu SL; Xu LQ; Chen G; Zhang C; Ju S; Liu ZG; You LK; Yu L; Zhou S
    J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):834-841. PubMed ID: 26670433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK
    George B; George SK; Shi W; Haque A; Shi P; Eskandari G; Axelson M; Larsson O; Kaseb AO; Amin HM
    J Hematol Oncol; 2019 Jul; 12(1):80. PubMed ID: 31340850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual treatments targeting IGF-1R, PI3K, mTORC or MEK synergize to inhibit cell growth, induce apoptosis, and arrest cell cycle at G1 phase in MDA-MB-231 cell line.
    Ayub A; Yip WK; Seow HF
    Biomed Pharmacother; 2015 Oct; 75():40-50. PubMed ID: 26463630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-lipoxygenase-1 expression upregulates and activates insulin-like growth factor-1 receptor in prostate cancer cells.
    Kelavkar UP; Cohen C
    Neoplasia; 2004; 6(1):41-52. PubMed ID: 15068670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
    van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
    Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells.
    Rao W; Li H; Song F; Zhang R; Yin Q; Wang Y; Xi Y; Ge H
    Carcinogenesis; 2014 Jul; 35(7):1573-81. PubMed ID: 24667688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclearly translocated insulin-like growth factor 1 receptor phosphorylates histone H3 at tyrosine 41 and induces SNAI2 expression via Brg1 chromatin remodeling protein.
    Warsito D; Lin Y; Gnirck AC; Sehat B; Larsson O
    Oncotarget; 2016 Jul; 7(27):42288-42302. PubMed ID: 27275536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition.
    Megiorni F; McDowell HP; Camero S; Mannarino O; Ceccarelli S; Paiano M; Losty PD; Pizer B; Shukla R; Pizzuti A; Clerico A; Dominici C
    J Exp Clin Cancer Res; 2015 Oct; 34():112. PubMed ID: 26445453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complex biology of the receptor for the insulin-like growth factor-1.
    Romano G
    Drug News Perspect; 2003 Oct; 16(8):525-31. PubMed ID: 14668950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for small molecule inhibitors of insulin-like growth factor receptor (IGF-1R) kinase: comparison of homogeneous time-resolved fluorescence and 33P-ATP plate assay formats.
    Wang Y; Malkowski M; Hailey J; Turek-Etienne T; Tripodi T; Pachter JA
    J Exp Ther Oncol; 2004 Jul; 4(2):111-9. PubMed ID: 15500006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.